Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 58, Issue 6, 2017, Pages 1424-1432

  De Luca, Luciana ^a   D’Arena, Giovanni ^a   Simeon, Vittorio ^a   Trino, Stefania ^a   Laurenzana, Ilaria ^a   Caivano, Antonella ^a   La Rocca, Francesco ^a   Villani, Oreste ^a   Mansueto, Giovanna ^a   Deaglio, Silvia ^b   Innocenti, Idanna ^c   Laurenti, Luca ^c   Molica, Stefano ^d   Pietrantuono, Giuseppe ^a   De Stradis, Angelo ^e   Del Vecchio, Luigi ^f,g   Musto, Pellegrino ^a  

^a REFERRAL CANCER CENTER OF BASILICATA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d PUGLIESE CIACCIO HOSPITAL   (Italy)

^e UNIVERSITY OF BARI   (Italy)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

Chronic lymphocytic leukemia; flow cytometry; microvesicles; prognosis

Indexed keywords

BENDAMUSTINE; CD19 ANTIGEN; CD2 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD37 ANTIGEN; CD38 ANTIGEN; CD52 ANTIGEN; CD56 ANTIGEN; CD81 ANTIGEN; CD94 ANTIGEN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; FLUDARABINE; LIPOCORTIN 5; RITUXIMAB; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; KARYOTYPE; LYMPHOCYTE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MEMBRANE MICROPARTICLE; MONOCYTE; NATURAL KILLER CELL; OVERALL SURVIVAL; PATIENT IDENTIFICATION; PHENOTYPE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TIME TO TREATMENT; TRANSMISSION ELECTRON MICROSCOPY; TUMOR VOLUME; BLOOD; BLOOD CELL COUNT; CANCER STAGING; CAUSE OF DEATH; EXOSOME; GENETIC VARIATION; IMMUNOPHENOTYPING; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; ULTRASTRUCTURE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; BIOMARKERS; BLOOD CELL COUNT; CAUSE OF DEATH; EXTRACELLULAR VESICLES; FEMALE; FLOW CYTOMETRY; GENETIC VARIATION; HUMANS; IMMUNOPHENOTYPING; KAPLAN-MEIER ESTIMATE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; ROC CURVE;

EID: 84991037515     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428194.2016.1243790     Document Type: Article

References (31)

1. Chiorazzi N, Rai KR, Ferrarini M., Chronic lymphocytic leukemia. N Engl J Med. 2005;352:804–815.
2. Hallek M., Chronic lymphocytic leukemia:2015 update on diagnosis, risk stratification, and treatment. Am J Hematol. 2015;90:446–460.
3. Eichhorst B, Robak T, Montserrat E, et al. Chronic lymphocytic leukaemia:ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26 Suppl 5:v78–v84.
4. Musto P, Negrini M, De Luca L, et al. Dissecting chronic lymphocytic leukemia with 13q- using microRNA expression profile. Leuk Res. 2016;47:114–115.
5. Caligaris-Cappio F, Bertilaccio MT, Scielzo C., How the microenvironment wires the natural history of chronic lymphocytic leukemia. Semin Cancer Biol. 2014;24:43–48.
6. Ghosh AK, Secreto CR, Knox TR, et al. Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells:implications for disease progression. Blood. 2010;115:1755–1764.
7. D'Arena G, Guariglia R, La Rocca F, et al. Autoimmune cytopenias in chronic lymphocytic leukemia. Clin Dev Immunol. 2013;2013:730131.
8. Gyorgy B, Szabo TG, Pasztoi M, et al. Membrane vesicles, current state-of-the-art:emerging role of extracellular vesicles. Cell Mol Life Sci. 2011;68:2667–2688.
9. ELA S, Mager I, Breakefield XO, Wood MJ., Extracellular vesicles:biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013;12:347–357.
10. Thakur BK, Zhang H, Becker A, et al. Double-stranded DNA in exosomes:a novel biomarker in cancer detection. Cell Res. 2014;24:766–769.
11. Li CC, Eaton SA, Young PE, et al. Glioma microvesicles carry selectively packaged coding and non-coding RNAs which alter gene expression in recipient cells. RNA Biol. 2013;10:1333–1344.
12. Huan J, Hornick NI, Shurtleff MJ, et al. RNA trafficking by acute myelogenous leukemia exosomes. Cancer Res. 2013;73:918–929.
13. De Luca L, Trino S, Laurenzana I, et al. MiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells:a new insight in transplantation. Oncotarget. 2016;7:6676–6692.
14. Turturici G, Tinnirello R, Sconzo G, et al. Extracellular membrane vesicles as a mechanism of cell-to-cell communication:advantages and disadvantages. Am J Physiol Cell Physiol. 2014;306:C621–C633.
15. Ratajczak J, Miekus K, Kucia M, et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors:evidence for horizontal transfer of mRNA and protein delivery. Leukemia. 2006;20:847–856.
16. Cai J, Han Y, Ren H, et al. Extracellular vesicle-mediated transfer of donor genomic DNA to recipient cells is a novel mechanism for genetic influence between cells. J Mol Cell Biol. 2013;5:227–238.
17. Zocco D, Ferruzzi P, Cappello F, et al. Extracellular vesicles as shuttles of tumor biomarkers and anti-tumor drugs. Front Oncol. 2014;4:267.
18. Gangoda L, Boukouris S, Liem M, et al. Extracellular vesicles including exosomes are mediators of signal transduction:are they protective or pathogenic? Proteomics. 2015;15:260–271.
19. Caivano A, Laurenzana I, De Luca L, et al. High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders. Tumor Biol. 2015;36:9739–9752.
20. Jayachandran M, Litwiller RD, Owen WG, et al. Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women. Am J Physiol Heart Circ Physiol. 2008;295:H931–H938.
21. Harrell FE, Jr., Lee KL, Mark DB., Multivariable prognostic models:issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–387.
22. Stilgenbauer S., Prognostic markers and standard management of chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program. 2015;2015:368–377.
23. Paggetti J, Haderk F, Seiffert M, et al. Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts. Blood. 2015;126:1106–1117.
24. Farahani M, Rubbi C, Liu L, et al. CLL exosomes modulate the transcriptome and behaviour of recipient stromal cells and are selectively enriched in miR-202-3p. PLoS One. 2015;10:e0141429.
25. Boysen J, Nelson M, Magzoub G, et al. Dynamics of microvesicle generation in B-cell chronic lymphocytic leukemia:implication in disease progression. Leukemia. 2016.
26. Yeh YY, Ozer HG, Lehman AM, et al. Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling. Blood. 2015;125:3297–3305.
27. Albitar M, Do KA, Johnson MM, et al. Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies. Cancer. 2004;101:999–1008.
28. Poncelet P, Robert S, Bouriche T, et al. Standardized counting of circulating platelet microparticles using currently available flow cytometers and scatter-based triggering:forward or side scatter?. Cytometry A. 2016;89:148–158.
29. Chandler WL., Measurement of microvesicle levels in human blood using flow cytometry. Cytometry B Clin Cytom. 2016;90:326–336.
30. Pospichalova V, Svoboda J, Dave Z, et al. Simplified protocol for flow cytometry analysis of fluorescently labeled exosomes and microvesicles using dedicated flow cytometer. J Extracell Vesicles. 2015;4:25530.
31. Witwer KW, Buzás EI, Bemis LT, et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2013;2:20360.